Jiangsu Lanfeng Bio-chemical Co Ltd Financial Flexibility Index
Jiangsu Lanfeng Bio-chemical Co Ltd financial flexibility index. Jiangsu Lanfeng Bio-chemical Co Ltd (002513) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-101.99 Million (operating CF CN¥-114.90 Million minus capex CN¥12.91 Million) represents 0% of total liabilities (CN¥4.42 Billion). See free cash flow generation of Jiangsu Lanfeng Bio-chemical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)
Financial flexibility index of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Jiangsu Lanfeng Bio-chemical Co Ltd across 19 annual periods. Check 002513 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Lanfeng Bio-chemical Co Ltd Financial Flexibility Index by Year (2007–2025)
Jiangsu Lanfeng Bio-chemical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Jiangsu Lanfeng Bio-chemical Co Ltd. For the full cash flow conversion analysis, see 002513 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | CN¥-231.09 Million | CN¥-376.00 Million | CN¥4.12 Billion | ▼ -145.4% |
| 2024 | 0.12x | CN¥383.42 Million | CN¥106.18 Million | CN¥3.11 Billion | ▲ +357.0% |
| 2023 | 0.03x | CN¥85.05 Million | CN¥-383.30 Million | CN¥3.15 Billion | ▲ +190.8% |
| 2022 | -0.03x | CN¥-33.25 Million | CN¥-64.34 Million | CN¥1.12 Billion | ▼ -131.4% |
| 2021 | 0.09x | CN¥100.67 Million | CN¥11.80 Million | CN¥1.06 Billion | ▼ -53.7% |
| 2020 | 0.21x | CN¥236.03 Million | CN¥128.31 Million | CN¥1.15 Billion | ▼ -7.4% |
| 2019 | 0.22x | CN¥347.01 Million | CN¥255.08 Million | CN¥1.57 Billion | ▲ +116.3% |
| 2018 | 0.10x | CN¥191.37 Million | CN¥73.30 Million | CN¥1.87 Billion | ▼ -14.0% |
| 2017 | 0.12x | CN¥178.50 Million | CN¥55.33 Million | CN¥1.50 Billion | ▼ -63.2% |
| 2016 | 0.32x | CN¥498.53 Million | CN¥335.70 Million | CN¥1.54 Billion | ▲ +46.1% |
| 2015 | 0.22x | CN¥360.66 Million | CN¥250.84 Million | CN¥1.63 Billion | ▲ +4.0% |
| 2014 | 0.21x | CN¥311.69 Million | CN¥127.97 Million | CN¥1.46 Billion | ▼ -6.2% |
| 2013 | 0.23x | CN¥318.79 Million | CN¥54.68 Million | CN¥1.40 Billion | ▼ -46.5% |
| 2012 | 0.42x | CN¥488.72 Million | CN¥58.88 Million | CN¥1.15 Billion | ▼ -51.3% |
| 2011 | 0.87x | CN¥534.65 Million | CN¥19.57 Million | CN¥612.09 Million | ▲ +78.4% |
| 2010 | 0.49x | CN¥282.51 Million | CN¥70.52 Million | CN¥577.14 Million | ▼ -29.6% |
| 2009 | 0.70x | CN¥286.24 Million | CN¥128.03 Million | CN¥411.64 Million | ▲ +23.8% |
| 2008 | 0.56x | CN¥157.74 Million | CN¥96.75 Million | CN¥280.73 Million | ▲ +28.3% |
| 2007 | 0.44x | CN¥132.56 Million | CN¥68.24 Million | CN¥302.71 Million | — |